{"gene":"POLD2","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1995,"finding":"POLD2 encodes the small (50 kDa) subunit of the heterodimeric core DNA polymerase delta enzyme; cDNA cloning and sequencing of bovine and human POLD2 established it as a component of the Pol δ core and localized the human gene to chromosome 7.","method":"cDNA cloning, sequencing, PCR analysis of human-hamster hybrid cell lines","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct molecular cloning and chromosomal mapping with functional inference from high sequence conservation; single lab, multiple orthogonal methods (cloning + hybrid panel mapping)","pmids":["8530069"],"is_preprint":false},{"year":1997,"finding":"The mouse POLD2 (50 kDa) subunit directly interacts with the 125 kDa catalytic subunit of DNA polymerase delta; yeast two-hybrid showed that the mouse catalytic subunit interacts with the human 50 kDa subunit, demonstrating interspecies interaction.","method":"Yeast two-hybrid system","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid interaction demonstrated across species, single lab, single method but replicated with interspecies pair","pmids":["9286699"],"is_preprint":false},{"year":1999,"finding":"Alignment of PolD2 sequences across ten eukaryotic species (including Xenopus XlCdc1) identified ten conserved regions (I–X) containing 36 invariant amino acid positions; known yeast mutant PolD2 alleles map within conserved regions III, VI, VII, and VIII, implicating these regions in essential function.","method":"Comparative sequence analysis; cDNA cloning; mapping of existing yeast mutants to conserved regions","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 4 / Moderate — primarily comparative/computational analysis with indirect support from yeast mutant mapping; no direct in vitro or in vivo functional assay","pmids":["10196469"],"is_preprint":false},{"year":2015,"finding":"The FF483-484 motif (F1 motif) of human DNA polymerase eta (Polη) mediates direct interaction with POLD2 (B subunit of Pol δ) both in vitro and in vivo; mutation of this motif impairs Polη-dependent bypass of an N-2-acetylaminofluorene adduct and a TT-CPD lesion in cellular extracts, reduces DNA synthesis progression after UV, and decreases cell survival after UV irradiation in XPV cells.","method":"In vitro binding assay, co-immunoprecipitation (in vivo), complementation of XPV cells with Polη mutants, cell survival assay, DNA synthesis assay in cellular extracts","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal in vitro and in vivo interaction, site-directed mutagenesis, functional rescue experiments in relevant cellular model, multiple orthogonal methods","pmids":["25662213"],"is_preprint":false},{"year":2012,"finding":"POLD2 interacts with PIAS2 (protein inhibitor of activated STAT2); the interaction was identified by yeast two-hybrid screening, confirmed by direct yeast two-hybrid, validated by co-immunoprecipitation in HEK-293 cells, and the two proteins were shown to partially co-localize in mammalian cells.","method":"Yeast two-hybrid screening, direct yeast two-hybrid, co-immunoprecipitation, subcellular co-localization","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — interaction confirmed by multiple methods (yeast two-hybrid + Co-IP + co-localization) in single lab; functional consequence not established","pmids":["22824807"],"is_preprint":false},{"year":2022,"finding":"POLD2 is essential for early murine embryogenesis; Pold2 knockout embryos develop normally to E3.5 blastocyst stage but fail at gastrulation, cannot hatch from zona pellucida, show slowed cellular proliferation, and exhibit skewed primitive endoderm and epiblast allocation; siRNA knockdown recapitulated these phenotypes.","method":"Genetic knockout in mouse, siRNA knockdown, outgrowth assay, blastocyst staging","journal":"Molecular reproduction and development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout with defined developmental phenotype, independently recapitulated by siRNA knockdown, multiple phenotypic readouts","pmids":["36528861"],"is_preprint":false},{"year":2022,"finding":"Transcription factor E2F1 directly binds the promoter of POLD2 and regulates its expression in triple-negative breast cancer (TNBC) cells; E2F1-mediated cell proliferation in TNBC is dependent on POLD2, as rescue experiments showed that POLD2 re-expression restores proliferation upon E2F1-driven induction.","method":"Promoter binding assay (ChIP or reporter), siRNA knockdown, rescue/overexpression experiments","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct promoter binding shown, functional epistasis confirmed by rescue, but single lab with limited methodological detail in abstract","pmids":["36119494"],"is_preprint":false},{"year":2020,"finding":"POLD2 knockdown inhibits GBM cell proliferation, cell cycle progression, and invasiveness, sensitizes GBM cells to chemo/radiation-induced cell death, and reverses the cytoprotective effects of EGFR signaling; forced POLD2 expression induces GBM cell proliferation, colony formation, invasiveness, and chemo/radiation resistance; shRNA-POLD2 combined with radiation dramatically inhibited orthotopic xenograft growth in vivo.","method":"siRNA/shRNA knockdown, forced overexpression, cell proliferation/cycle/invasion assays, orthotopic xenograft mouse model, radiation treatment","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function with multiple phenotypic readouts including in vivo model; pathway placement (EGFR signaling connection) is functional but mechanistic detail is limited","pmids":["31954770"],"is_preprint":false}],"current_model":"POLD2 encodes the conserved B (p50) subunit of the heterodimeric core DNA polymerase delta complex, where it directly interacts with the catalytic (p125) subunit; it serves as a docking platform for the translesion synthesis polymerase Polη (via Polη's FF483-484 motif) to facilitate replication-coupled DNA damage bypass, is transcriptionally activated by E2F1, and is essential for early mammalian embryogenesis and cellular proliferation, with its loss sensitizing cells to DNA-damaging agents."},"narrative":{"mechanistic_narrative":"POLD2 encodes the conserved small (50 kDa, B) subunit of the heterodimeric core DNA polymerase delta enzyme, where it directly binds the 125 kDa catalytic subunit to form the functional polymerase core [PMID:8530069, PMID:9286699]. Beyond its structural role in the core complex, POLD2 acts as a docking platform that recruits the translesion synthesis polymerase Polη: Polη's FF483-484 (F1) motif binds POLD2 directly, and disrupting this interaction impairs bypass of bulky DNA adducts and UV-induced TT-CPD lesions, slows post-UV DNA synthesis, and reduces survival of XPV cells after UV irradiation, linking POLD2 to replication-coupled DNA damage tolerance [PMID:25662213]. POLD2 is transcriptionally controlled by E2F1, which binds its promoter and drives proliferation through POLD2 in triple-negative breast cancer cells [PMID:36119494]. Consistent with an essential replicative function, Pold2 is required for cellular proliferation and early mammalian development, with knockout embryos arresting at gastrulation [PMID:36528861], and its loss impairs tumor cell proliferation and sensitizes glioblastoma cells to chemo- and radiotherapy [PMID:31954770]. Conserved sequence regions harboring essential-function residues have been mapped across eukaryotic orthologs [PMID:10196469].","teleology":[{"year":1995,"claim":"Established the molecular identity of POLD2 as the small subunit of the core Pol δ enzyme, defining the gene product whose function would later be dissected.","evidence":"cDNA cloning and sequencing of bovine and human POLD2 with chromosomal mapping via human-hamster hybrid panels","pmids":["8530069"],"confidence":"Medium","gaps":["Function inferred from conservation rather than direct biochemical assay","Role within the holoenzyme not yet defined"]},{"year":1997,"claim":"Demonstrated that the 50 kDa subunit directly contacts the 125 kDa catalytic subunit, establishing the physical architecture of the Pol δ core heterodimer.","evidence":"Yeast two-hybrid with interspecies mouse/human subunit pairs","pmids":["9286699"],"confidence":"Medium","gaps":["Interaction interface not mapped","Single method without structural confirmation","Functional consequence of the interaction not tested"]},{"year":1999,"claim":"Identified conserved sequence regions and invariant residues across eukaryotic orthologs, implicating specific regions in essential function via yeast mutant mapping.","evidence":"Comparative sequence analysis across ten species with mapping of known yeast mutant alleles","pmids":["10196469"],"confidence":"Low","gaps":["Purely computational with indirect mutant support","No direct functional assay of the conserved regions in human protein"]},{"year":2012,"claim":"Identified PIAS2 as a POLD2 interaction partner, raising the possibility of regulatory or SUMO-pathway connections.","evidence":"Yeast two-hybrid screen, direct two-hybrid, Co-IP in HEK-293, and co-localization","pmids":["22824807"],"confidence":"Medium","gaps":["Functional consequence of interaction not established","Biological context unknown"]},{"year":2015,"claim":"Revealed a non-replicative role for POLD2 as a recruitment platform for translesion polymerase Polη, connecting the Pol δ subunit to DNA damage bypass.","evidence":"In vitro binding, in vivo Co-IP, FF483-484 motif mutagenesis, and functional rescue/survival assays in XPV cells","pmids":["25662213"],"confidence":"High","gaps":["Structural basis of the POLD2-Polη interface not resolved","Whether other TLS polymerases use the same docking site unknown"]},{"year":2020,"claim":"Showed POLD2 drives tumor cell proliferation, invasion, and therapy resistance, positioning it as a determinant of DNA damage response in cancer.","evidence":"Knockdown/overexpression with proliferation, cycle, invasion assays and orthotopic glioblastoma xenografts with radiation","pmids":["31954770"],"confidence":"Medium","gaps":["Molecular link to EGFR signaling not mechanistically defined","Whether effects depend on Pol δ core function or TLS role unclear"]},{"year":2022,"claim":"Established POLD2 as essential for cellular proliferation and early mammalian embryogenesis, confirming its non-redundant developmental requirement.","evidence":"Mouse knockout with blastocyst staging and outgrowth assays, recapitulated by siRNA knockdown","pmids":["36528861"],"confidence":"High","gaps":["Cause of gastrulation failure at molecular level not defined","Tissue-specific requirements not dissected"]},{"year":2022,"claim":"Placed POLD2 downstream of E2F1 transcriptional control, linking cell-cycle transcription factors to POLD2-dependent proliferation in cancer.","evidence":"Promoter binding assay, siRNA knockdown, and rescue/overexpression in TNBC cells","pmids":["36119494"],"confidence":"Medium","gaps":["Direct ChIP-defined binding site not detailed","Generality beyond TNBC unknown"]},{"year":null,"claim":"How POLD2's roles in the Pol δ core versus TLS polymerase recruitment are coordinated, and the structural and regulatory basis of its partner interactions, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the POLD2-containing core or its damage-bypass docking complex","Functional role of the PIAS2 interaction unestablished","Mechanistic basis of cancer therapy resistance undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[0,1]}],"complexes":["DNA polymerase delta core complex"],"partners":["POLD1","POLH","PIAS2","E2F1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49005","full_name":"DNA polymerase delta subunit 2","aliases":["DNA polymerase delta subunit p50"],"length_aa":469,"mass_kda":51.3,"function":"Accessory component of both the DNA polymerase delta complex and the DNA polymerase zeta complex (PubMed:17317665, PubMed:22801543, PubMed:24449906). As a component of the trimeric and tetrameric DNA polymerase delta complexes (Pol-delta3 and Pol-delta4, respectively), plays a role in high fidelity genome replication, including in lagging strand synthesis, and repair (PubMed:12403614, PubMed:16510448, PubMed:19074196, PubMed:20334433, PubMed:24035200). Pol-delta3 and Pol-delta4 are characterized by the absence or the presence of POLD4. They exhibit differences in catalytic activity. Most notably, Pol-delta3 shows higher proofreading activity than Pol-delta4 (PubMed:19074196, PubMed:20334433). Although both Pol-delta3 and Pol-delta4 process Okazaki fragments in vitro, Pol-delta3 may also be better suited to fulfill this task, exhibiting near-absence of strand displacement activity compared to Pol-delta4 and stalling on encounter with the 5'-blocking oligonucleotides. Pol-delta3 idling process may avoid the formation of a gap, while maintaining a nick that can be readily ligated (PubMed:24035200). Along with DNA polymerase kappa, DNA polymerase delta carries out approximately half of nucleotide excision repair (NER) synthesis following UV irradiation (PubMed:20227374). Under conditions of DNA replication stress, required for the repair of broken replication forks through break-induced replication (BIR) (PubMed:24310611). Involved in the translesion synthesis (TLS) of templates carrying O6-methylguanine or abasic sites performed by Pol-delta4, independently of DNA polymerase zeta (REV3L) or eta (POLH). Facilitates abasic site bypass by DNA polymerase delta by promoting extension from the nucleotide inserted opposite the lesion. Also involved in TLS as a component of the DNA polymerase zeta complex (PubMed:24449906). Along with POLD3, dramatically increases the efficiency and processivity of DNA synthesis of the DNA polymerase zeta complex compared to the minimal zeta complex, consisting of only REV3L and REV7 (PubMed:24449906)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49005/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLD2","classification":"Common Essential","n_dependent_lines":1179,"n_total_lines":1208,"dependency_fraction":0.9759933774834437},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POLD2","total_profiled":1310},"omim":[{"mim_id":"620869","title":"IMMUNODEFICIENCY 122; IMD122","url":"https://www.omim.org/entry/620869"},{"mim_id":"613421","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 10; KCTD10","url":"https://www.omim.org/entry/613421"},{"mim_id":"611525","title":"POLYMERASE (DNA-DIRECTED), DELTA 4; POLD4","url":"https://www.omim.org/entry/611525"},{"mim_id":"611520","title":"POLYMERASE DELTA-INTERACTING PROTEIN 3; POLDIP3","url":"https://www.omim.org/entry/611520"},{"mim_id":"611519","title":"POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2","url":"https://www.omim.org/entry/611519"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLD2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P49005","domains":[{"cath_id":"3.60.21.50","chopping":"4-11_24-42_184-253_269-452","consensus_level":"high","plddt":93.015,"start":4,"end":452},{"cath_id":"2.40.50.430","chopping":"51-107_124-178","consensus_level":"high","plddt":94.419,"start":51,"end":178}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49005","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49005-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49005-F1-predicted_aligned_error_v6.png","plddt_mean":89.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLD2","jax_strain_url":"https://www.jax.org/strain/search?query=POLD2"},"sequence":{"accession":"P49005","fasta_url":"https://rest.uniprot.org/uniprotkb/P49005.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49005/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49005"}},"corpus_meta":[{"pmid":"21079801","id":"PMC_21079801","title":"POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21079801","citation_count":31,"is_preprint":false},{"pmid":"8530069","id":"PMC_8530069","title":"Cloning of the cDNAs for the small subunits of bovine and human DNA polymerase delta and chromosomal location of the human gene (POLD2).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530069","citation_count":31,"is_preprint":false},{"pmid":"25662213","id":"PMC_25662213","title":"FF483-484 motif of human Polη mediates its interaction with the POLD2 subunit of Polδ and contributes to DNA damage tolerance.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25662213","citation_count":26,"is_preprint":false},{"pmid":"23198659","id":"PMC_23198659","title":"Characterization of Mycobacterium smegmatis PolD2 and PolD1 as RNA/DNA polymerases homologous to the POL domain of bacterial DNA ligase D.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23198659","citation_count":20,"is_preprint":false},{"pmid":"31954770","id":"PMC_31954770","title":"ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/31954770","citation_count":12,"is_preprint":false},{"pmid":"36119494","id":"PMC_36119494","title":"POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36119494","citation_count":12,"is_preprint":false},{"pmid":"10196469","id":"PMC_10196469","title":"Characterisation of XlCdc1, a Xenopus homologue of the small (PolD2) subunit of DNA polymerase delta; identification of ten conserved regions I-X based on protein sequence comparisons across ten eukaryotic species.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10196469","citation_count":11,"is_preprint":false},{"pmid":"34116171","id":"PMC_34116171","title":"Exome sequencing reveals novel rare variants in Iranian familial multiple sclerosis: The importance of POLD2 in the disease pathogenesis.","date":"2021","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34116171","citation_count":10,"is_preprint":false},{"pmid":"9286699","id":"PMC_9286699","title":"Cloning, chromosomal localization, and interspecies interaction of mouse DNA polymerase delta small subunit (PolD2).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9286699","citation_count":6,"is_preprint":false},{"pmid":"36528861","id":"PMC_36528861","title":"Early embryonic lethality of mice lacking POLD2.","date":"2022","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/36528861","citation_count":5,"is_preprint":false},{"pmid":"22824807","id":"PMC_22824807","title":"Identification of Pold2 as a novel interaction partner of protein inhibitor of activated STAT2.","date":"2012","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22824807","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.20.649719","title":"Greater Expression of DNA Repair Pathways in Sharks vs. Rays/Skates Based on Transcriptomic Analyses","date":"2025-04-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.20.649719","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.02.673780","title":"BOGO: A Proteome-Wide Gene Overexpression Platform for Discovering Rational Cancer Combination Therapies","date":"2025-09-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.02.673780","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7904,"output_tokens":1997,"usd":0.026833,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9035,"output_tokens":2573,"usd":0.05475,"stage2_stop_reason":"end_turn"},"total_usd":0.081583,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"POLD2 encodes the small (50 kDa) subunit of the heterodimeric core DNA polymerase delta enzyme; cDNA cloning and sequencing of bovine and human POLD2 established it as a component of the Pol δ core and localized the human gene to chromosome 7.\",\n      \"method\": \"cDNA cloning, sequencing, PCR analysis of human-hamster hybrid cell lines\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct molecular cloning and chromosomal mapping with functional inference from high sequence conservation; single lab, multiple orthogonal methods (cloning + hybrid panel mapping)\",\n      \"pmids\": [\"8530069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The mouse POLD2 (50 kDa) subunit directly interacts with the 125 kDa catalytic subunit of DNA polymerase delta; yeast two-hybrid showed that the mouse catalytic subunit interacts with the human 50 kDa subunit, demonstrating interspecies interaction.\",\n      \"method\": \"Yeast two-hybrid system\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid interaction demonstrated across species, single lab, single method but replicated with interspecies pair\",\n      \"pmids\": [\"9286699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Alignment of PolD2 sequences across ten eukaryotic species (including Xenopus XlCdc1) identified ten conserved regions (I–X) containing 36 invariant amino acid positions; known yeast mutant PolD2 alleles map within conserved regions III, VI, VII, and VIII, implicating these regions in essential function.\",\n      \"method\": \"Comparative sequence analysis; cDNA cloning; mapping of existing yeast mutants to conserved regions\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — primarily comparative/computational analysis with indirect support from yeast mutant mapping; no direct in vitro or in vivo functional assay\",\n      \"pmids\": [\"10196469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The FF483-484 motif (F1 motif) of human DNA polymerase eta (Polη) mediates direct interaction with POLD2 (B subunit of Pol δ) both in vitro and in vivo; mutation of this motif impairs Polη-dependent bypass of an N-2-acetylaminofluorene adduct and a TT-CPD lesion in cellular extracts, reduces DNA synthesis progression after UV, and decreases cell survival after UV irradiation in XPV cells.\",\n      \"method\": \"In vitro binding assay, co-immunoprecipitation (in vivo), complementation of XPV cells with Polη mutants, cell survival assay, DNA synthesis assay in cellular extracts\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal in vitro and in vivo interaction, site-directed mutagenesis, functional rescue experiments in relevant cellular model, multiple orthogonal methods\",\n      \"pmids\": [\"25662213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"POLD2 interacts with PIAS2 (protein inhibitor of activated STAT2); the interaction was identified by yeast two-hybrid screening, confirmed by direct yeast two-hybrid, validated by co-immunoprecipitation in HEK-293 cells, and the two proteins were shown to partially co-localize in mammalian cells.\",\n      \"method\": \"Yeast two-hybrid screening, direct yeast two-hybrid, co-immunoprecipitation, subcellular co-localization\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — interaction confirmed by multiple methods (yeast two-hybrid + Co-IP + co-localization) in single lab; functional consequence not established\",\n      \"pmids\": [\"22824807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"POLD2 is essential for early murine embryogenesis; Pold2 knockout embryos develop normally to E3.5 blastocyst stage but fail at gastrulation, cannot hatch from zona pellucida, show slowed cellular proliferation, and exhibit skewed primitive endoderm and epiblast allocation; siRNA knockdown recapitulated these phenotypes.\",\n      \"method\": \"Genetic knockout in mouse, siRNA knockdown, outgrowth assay, blastocyst staging\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout with defined developmental phenotype, independently recapitulated by siRNA knockdown, multiple phenotypic readouts\",\n      \"pmids\": [\"36528861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Transcription factor E2F1 directly binds the promoter of POLD2 and regulates its expression in triple-negative breast cancer (TNBC) cells; E2F1-mediated cell proliferation in TNBC is dependent on POLD2, as rescue experiments showed that POLD2 re-expression restores proliferation upon E2F1-driven induction.\",\n      \"method\": \"Promoter binding assay (ChIP or reporter), siRNA knockdown, rescue/overexpression experiments\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct promoter binding shown, functional epistasis confirmed by rescue, but single lab with limited methodological detail in abstract\",\n      \"pmids\": [\"36119494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLD2 knockdown inhibits GBM cell proliferation, cell cycle progression, and invasiveness, sensitizes GBM cells to chemo/radiation-induced cell death, and reverses the cytoprotective effects of EGFR signaling; forced POLD2 expression induces GBM cell proliferation, colony formation, invasiveness, and chemo/radiation resistance; shRNA-POLD2 combined with radiation dramatically inhibited orthotopic xenograft growth in vivo.\",\n      \"method\": \"siRNA/shRNA knockdown, forced overexpression, cell proliferation/cycle/invasion assays, orthotopic xenograft mouse model, radiation treatment\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function with multiple phenotypic readouts including in vivo model; pathway placement (EGFR signaling connection) is functional but mechanistic detail is limited\",\n      \"pmids\": [\"31954770\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLD2 encodes the conserved B (p50) subunit of the heterodimeric core DNA polymerase delta complex, where it directly interacts with the catalytic (p125) subunit; it serves as a docking platform for the translesion synthesis polymerase Polη (via Polη's FF483-484 motif) to facilitate replication-coupled DNA damage bypass, is transcriptionally activated by E2F1, and is essential for early mammalian embryogenesis and cellular proliferation, with its loss sensitizing cells to DNA-damaging agents.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLD2 encodes the conserved small (50 kDa, B) subunit of the heterodimeric core DNA polymerase delta enzyme, where it directly binds the 125 kDa catalytic subunit to form the functional polymerase core [#0, #1]. Beyond its structural role in the core complex, POLD2 acts as a docking platform that recruits the translesion synthesis polymerase Pol\\u03b7: Pol\\u03b7's FF483-484 (F1) motif binds POLD2 directly, and disrupting this interaction impairs bypass of bulky DNA adducts and UV-induced TT-CPD lesions, slows post-UV DNA synthesis, and reduces survival of XPV cells after UV irradiation, linking POLD2 to replication-coupled DNA damage tolerance [#3]. POLD2 is transcriptionally controlled by E2F1, which binds its promoter and drives proliferation through POLD2 in triple-negative breast cancer cells [#6]. Consistent with an essential replicative function, Pold2 is required for cellular proliferation and early mammalian development, with knockout embryos arresting at gastrulation [#5], and its loss impairs tumor cell proliferation and sensitizes glioblastoma cells to chemo- and radiotherapy [#7]. Conserved sequence regions harboring essential-function residues have been mapped across eukaryotic orthologs [#2].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the molecular identity of POLD2 as the small subunit of the core Pol \\u03b4 enzyme, defining the gene product whose function would later be dissected.\",\n      \"evidence\": \"cDNA cloning and sequencing of bovine and human POLD2 with chromosomal mapping via human-hamster hybrid panels\",\n      \"pmids\": [\"8530069\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Function inferred from conservation rather than direct biochemical assay\", \"Role within the holoenzyme not yet defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that the 50 kDa subunit directly contacts the 125 kDa catalytic subunit, establishing the physical architecture of the Pol \\u03b4 core heterodimer.\",\n      \"evidence\": \"Yeast two-hybrid with interspecies mouse/human subunit pairs\",\n      \"pmids\": [\"9286699\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction interface not mapped\", \"Single method without structural confirmation\", \"Functional consequence of the interaction not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified conserved sequence regions and invariant residues across eukaryotic orthologs, implicating specific regions in essential function via yeast mutant mapping.\",\n      \"evidence\": \"Comparative sequence analysis across ten species with mapping of known yeast mutant alleles\",\n      \"pmids\": [\"10196469\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Purely computational with indirect mutant support\", \"No direct functional assay of the conserved regions in human protein\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified PIAS2 as a POLD2 interaction partner, raising the possibility of regulatory or SUMO-pathway connections.\",\n      \"evidence\": \"Yeast two-hybrid screen, direct two-hybrid, Co-IP in HEK-293, and co-localization\",\n      \"pmids\": [\"22824807\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of interaction not established\", \"Biological context unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed a non-replicative role for POLD2 as a recruitment platform for translesion polymerase Pol\\u03b7, connecting the Pol \\u03b4 subunit to DNA damage bypass.\",\n      \"evidence\": \"In vitro binding, in vivo Co-IP, FF483-484 motif mutagenesis, and functional rescue/survival assays in XPV cells\",\n      \"pmids\": [\"25662213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the POLD2-Pol\\u03b7 interface not resolved\", \"Whether other TLS polymerases use the same docking site unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed POLD2 drives tumor cell proliferation, invasion, and therapy resistance, positioning it as a determinant of DNA damage response in cancer.\",\n      \"evidence\": \"Knockdown/overexpression with proliferation, cycle, invasion assays and orthotopic glioblastoma xenografts with radiation\",\n      \"pmids\": [\"31954770\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link to EGFR signaling not mechanistically defined\", \"Whether effects depend on Pol \\u03b4 core function or TLS role unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established POLD2 as essential for cellular proliferation and early mammalian embryogenesis, confirming its non-redundant developmental requirement.\",\n      \"evidence\": \"Mouse knockout with blastocyst staging and outgrowth assays, recapitulated by siRNA knockdown\",\n      \"pmids\": [\"36528861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of gastrulation failure at molecular level not defined\", \"Tissue-specific requirements not dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placed POLD2 downstream of E2F1 transcriptional control, linking cell-cycle transcription factors to POLD2-dependent proliferation in cancer.\",\n      \"evidence\": \"Promoter binding assay, siRNA knockdown, and rescue/overexpression in TNBC cells\",\n      \"pmids\": [\"36119494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP-defined binding site not detailed\", \"Generality beyond TNBC unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How POLD2's roles in the Pol \\u03b4 core versus TLS polymerase recruitment are coordinated, and the structural and regulatory basis of its partner interactions, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the POLD2-containing core or its damage-bypass docking complex\", \"Functional role of the PIAS2 interaction unestablished\", \"Mechanistic basis of cancer therapy resistance undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"DNA polymerase delta core complex\"],\n    \"partners\": [\"POLD1\", \"POLH\", \"PIAS2\", \"E2F1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}